Robert B. Cameron, MD
Accepting new patients

Robert B. Cameron, MD

  • Thoracic Surgery
Thoracic Surgery | 100 Medical Plaza, Suite 700, Los Angeles, CA 90095
310-267-9099

About

I am a Professor of cardiothoracic surgery and surgical oncology at the David Geffen School of Medicine at UCLA, Founding Chief of the Division of Thoracic Surgery, Chief of the Division of Thoracic Surgery at the West Los Angeles VA Medical Center and as a thoracic (chest) surgeon and surgical oncologist (cancer surgeon), I specialize in surgery of the lungs, pleura, esophagus, chest wall, mediastinum, and diaphragm. Specific areas of expertise include mesothelioma, esophageal cancer, lung cancer, thymus tumors, pectus deformities (excavatum or carinatum), hyperhidrosis, thoracic outlet syndrome, and lung volume reduction surgery (LVRS). I offer a broad range of services in the field of surgical chest diseases from cancer screening to radical surgery and the most advanced clinical treatment trials. I use the entire range of latest surgical techniques, including lasers, bronchial (airway) and esophageal stents, video- and computer-assisted (robotic) surgery.

Languages

English

Education

Medical Board Certifications

Thoracic and Cardiac Surgery, American Board of Thoracic Surgery, 1995
Surgery, American Board of Surgery, 1993

Fellowships

Thoracic Surgery, New York Hospital - Cornell University Medical Ctr, 1994
Surgical Oncology, National Cancer Institute, 1989

Residencies

Surgery, UCLA School of Medicine, 1992
Surgery, UCLA School of Medicine, 1986

Internship

Surgery, UCLA School of Medicine, 1985

Degree

MD, UCLA School of Medicine, 1984

Recognitions

Locations

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Videos

Improve Treatment Options for Patients with Mesothelioma | UCLA Health Vital Signs
Diffuse" Pleural Mesothelioma: Implications for Surgical Technique (4th Annual Mesothelioma Symposium)
Options for Intraoperative Adjuvant Therapies (6th Annual Mesothelioma Symposium)
Surgery for Mesothelioma: Is There A Future? (7th Annual Mesothelioma Symposium)
Treatment of Mesothelioma as a Sarcoma (3rd Annual Mesothelioma Symposium)
Surgical Approaches to Mesothelioma

Research

Interests

Dr. Cameron is interested in minimally-invasive and robotic thoracic surgery including robotic surgery of the lung, mediastinum, esophagus, and thymus as well as surgery for malignant pleural mesothelioma, esophageal cancer, lung cancer, thymectomy, hyperhidrosis, lung volume reduction surgery, pectus excavatum, chest wall tumors (sarcomas), and thoracic outlet syndrome

Publications

  1. Li GC, Cameron RB, Sapareto S, and Hahn GM. Reinterpretation of the Arrhenius analysis of cell inactivation by heat. Third International Symposium: Cancer Therapy by Hyperthermia, Drugs, and Radiation. NCI Monograph 61:111-113, 1982.
  2. Moore TC and Cameron RB. Spontaneous perforation of the extrahepatic biliary tract in infancy and childhood. Pediatr Surg Int 1:206-209, 1986.
  3. Cameron RB, McIntosh JK, and Rosenberg SA. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases. Cancer Res 48(20):5810-5817, 1988.
  4. Eisenthal A, Cameron RB, Uppenkamp I, and Rosenberg SA. Effect of combined therapy with lymphokine-activated killer cells, interleukin-2, and specific monoclonal antibody on established B16 melanoma lung metastases. Cancer Res 48(24):7140-7145, 1988.
  5. Cameron RB, Spiess PJ, and Rosenberg SA. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin-2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med 171(1):249-263, 1990.
  6. Eisenthal A, Cameron RB, and Rosenberg SA. Induction of antibody-dependent cellular cytotoxicity in vivo with specific anti-B16 monoclonal antibody. J Immunol 144(11):4463-4471, 1990.
  7. Bock SN, Cameron RB, Kragel P, Mule JJ, and Rosenberg SA. Biologic and antitumor effects of recombinant human macrophage colony stimulating factor in mice. Cancer Res 51(10):2649-2654, 1991.
  8. Barsky SH, Cameron RB, Osann KE, Tomita DK, and Holmes AC. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathological features. Cancer 73(4):1163-1170, 1994.
  9. Cameron RB, Fringer J, Taylor C, Gilden R, and Figlin RA. Practice guidelines for non-small cell lung cancer. Cancer J Sci Am 2(3A suppl):61-68, 1996.
  10. Cameron RB, Smith NG, Taylor C, Gilden R, and Figlin RA. Practice guidelines for small cell lung cancer. Cancer J Sci Am 2(3A suppl):69-75, 1996.


Link to Dr. Cameron's Google Scholar >

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  • Top Doctors, Los Angeles Magazine, 2024
  • Super Doctors® Southern California 2023, 2024
  • Super Doctors® Southern California 2011-2022
  • America's Top Doctors, 2007-2022

Links